Holen Sie sich die Stockscreener-App
5.70
26.26%
-2.03
Schlusskurs vom Vortag:
$7.73
Offen:
$6.1
24-Stunden-Volumen:
378.55K
Relative Volume:
1.06
Marktkapitalisierung:
$6.43M
Einnahmen:
$72,100
Nettoeinkommen (Verlust:
$-4.84M
KGV:
-0.7644
EPS:
-7.4566
Netto-Cashflow:
$-3.84M
1W Leistung:
-7.77%
1M Leistung:
-10.94%
6M Leistung:
-3.21%
1J Leistung:
-39.54%
1-Tages-Spanne:
$5.37
$6.30
1-Wochen-Bereich:
$5.37
$7.95
52-Wochen-Spanne:
$3.315
$15.15
Silo Pharma Inc Stock (SILO) Company Profile
Firmenname
Silo Pharma Inc
Sektor
Branche
Telefon
(718) 400-9031
Adresse
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.50 | 3.32B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.04 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.26 | 327.48M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.45 | 292.26M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.47 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Aktie (SILO) Neueste Nachrichten
Number of shareholders of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
Price to sales forward of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall - Investing.com Canada
SILO: H.C. Wainwright & Co. Leads Exclusive Offering - GuruFocus
Silo Pharma (SILO) Stock Tumbles 28% Following $4M Financing Announcement - Blockonomi
Silo Pharma (SILO) Stock: Shares Plunge 28% After $4 Million Private Placement - CoinCentral
Silo Pharma Sinks on Stock Sale - Baystreet.ca
Silo Pharma Shares Slide After Announcing Up to $11.7 Million Private Placement (SILO) - Yahoo Finance
Silo Pharma Launches Private Placement to Raise Up to $11.7 Million - Moomoo
Silo Pharma raises $4 million in private placement - Investing.com
Silo Pharma stock tumbles 22% on dilutive private placement - Investing.com
Silo Pharma stock tumbles 22% on dilutive private placement By Investing.com - Investing.com Australia
Silo Pharma Announces $4 Million Private Placement with Up to Approximately $7.7 Million in Potential Additional Gross Proceeds from Warrants - Quiver Quantitative
Biotech Silo Pharma lines up $11.7M in stock and warrant funding - Stock Titan
Certara, Silo Pharma advance AI agent strategies with Nvidia initiatives - MSN
SILO Pharma Inc (NASDAQ:SILO) - intelligentinvestor.com.au
AdvisorShares Trust (NASDAQ: SILO) holds 6.69% of Silo Pharma - Stock Titan
Nvidia Powers AI Agent Strategies for Certara, Silo PharmaNVIDIA (NASDAQ:NVDA) - Benzinga
Nasdaq most active stocks: - MSN
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program - The Manila Times
Silo Pharma subsidiary joins NVIDIA developer program By Investing.com - Investing.com Canada
Silo Pharma Subsidiary QwikAgents Joins NVIDIA Developer Program to Advance AI Agent Platform - Quiver Quantitative
Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering - Investing News Network
Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on February 23, 2026. - marketscreener.com
Why Did SILO Stock Soar 85% Today? - Stocktwits
Silo Pharma Advances SPC-15 Intranasal PTSD Program With Device Robustness Study - citybuzz -
Form DEF 14A SILO PHARMA For: 30 June By Investing.com - Investing.com Nigeria
Silo Pharma (SILO) sets 2026 meeting on directors, auditor and stock increase - Stock Titan
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request - The Manila Times
Silo Pharma Advances SPC-15 PTSD Therapeutic With Drug-Device Robustness Study Ahead Of Planned FDA Type C Meeting Request - marketscreener.com
Silo Pharma Inc (SILO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial - Sahm
Silo Pharma reports positive stability data for stress treatment SPC-15 - TipRanks
Silo Pharma reports stability data for intranasal drug SPC-15 By Investing.com - Investing.com Canada
Silo Pharma Says SPC-15 PTSD Nasal Spray Remains Stable for 9 Months - marketscreener.com
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD - GlobeNewswire
Silo Pharma Inc (SILO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Silo Pharma Regains Nasdaq Compliance, Stabilizing Listing Status - The Globe and Mail
Silo Pharma regains compliance with Nasdaq min bid price requirement - TipRanks
Silo Pharma Regains Nasdaq Compliance and Advances PTSD Drug SPC-15 Toward Clinical Trials - Minichart
SILO News | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
Silo Pharma regains Nasdaq minimum bid price compliance, ticker SILO - TradingView
Silo Pharma (SILO) to vote on director slate, auditor and stock increase at Aug 14 meeting - Stock Titan
Silo Pharma (SILO) restores Nasdaq minimum bid price compliance status - Stock Titan
Silo Pharma Says it Regained Compliance With Nasdaq's Minimum Bid Price Requirement - marketscreener.com
Silo Pharma Regains Nasdaq Compliance - Intellectia AI
Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement - TradingView
Silo Pharma regains Nasdaq minimum bid price compliance By Investing.com - Investing.com India
Silo Pharma clears Nasdaq’s bid-price test; stock stays listed - Stock Titan
Silo Pharma Inc (SILO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Silo Pharma Inc (SILO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Finanzdaten der Silo Pharma Inc-Aktie (SILO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Silo Pharma Inc-Aktie (SILO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.37 |
1,000 |
370 |
210,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.36 |
1,000 |
365 |
211,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 18 '25 |
Buy |
0.40 |
7,500 |
3,025 |
205,432 |
| Weisblum Eric | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.41 |
4,500 |
1,823 |
209,932 |
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):